Cephalalgia
@JCephalalgia
The official journal for the International Headache Society @ihs_official, 2-year Impact Factor: 4.6, 5-year IF: 5, Gold Open Access January 2023
New in Cephalalgia A post-hoc analysis of a phase 2/3, open-label study of rimegepant in the acute treatment of migraine according to current and historical triptan use. Rimegepant 75 mg administered up to once per day as PRN (52 weeks) or EOD+PRN (12 weeks) was safe and well…

✨🧠 New Topical Collection in Cephalalgia! ✨🧠 "Toward International Classification of Headache Disorders – 4 (ICHD-4)" 📍OPEN TO SUBMISSIONS As we look ahead to the next edition of the ICHD, this collection invites high-level contributions to address current limitations,…

Sumatriptan did not prevent KATP channel opener-induced migraine but reduced headache intensity. Highlights KATP channels as key migraine targets. journals.sagepub.com/doi/10.1177/03… #migraine #headache #brain #pain #neurology #neuroscience @MessoudAshina @ZxZhAlice @Alkaragholi_MM…

New in Cephalalgia! How does migraine with aura (MA) alter brain structure beyond the visual cortex? 🧠 ⚡Using structural MRI and network-based analysis, this study reveals altered grey-matter (GM) network topology in MA: ➡️ Right lingual gyrus: Increased nodal degree in MA…

New in Cephalalgia! Fibromyalgia (FM) is a common comorbidity in chronic migraine (CM), but how it affects treatment response has remained unclear. 📌 This prospective, proof-of-concept study compared treatment responsiveness to flunarizine in patients with: - Chronic migraine…

Welcome on board to the new Fellows of the @JCephalalgia Reviewer Academy @ihs_official
📢 We are delighted to officially welcome the 2025/2026 Cephalalgia Reviewer Academy Fellows! 🎉 These outstanding early-career researchers from around the world have been selected for their commitment to excellence in headache research and scientific publishing. Over the next…
Socioeconomic disparities in access to migraine therapy persist—even in publicly funded healthcare systems. In a population-based nested case-control study from Region Stockholm (N = 52,996), researchers examined the association between socioeconomic status (SES) and first-time…

🧒🧠 Call for Papers: Cephalalgia Topical Collection – Headache in Children and Adolescents Guest Editors: Andrew Hershey, Aynur Ozge, Massimiliano Valeriani Headache disorders in pediatric populations are common, complex, and often under-recognized. This Topical Collection of…

New in Cephalalgia Reports! A cross-sectional study examines real-world data from patients with cluster headache (CH) referred to a tertiary headache center. Key findings: ✔️ 54% had chronic CH ❌ 34% lacked first-line acute therapy ❌ 55% had not received guideline-recommended…

🌍🧠 Migraine Care Around the World – A New Collection in Cephalalgia Reports Migraine is a global burden—but access to care is far from equal. Our new topical collection spotlights the diverse challenges, innovations, and inequalities in migraine care across regions like Latin…

New Research published in @Cephreports! Combined #SPG and #GON blocks for patients with refractory #cluster headache @ihs_officialhttps://doi.org/10.1177/25158163251355554 @JCephalalgia @Simona_Sacco_
Postprandial #lasmiditan intake may be associated with reduced side effects compared with fasting intake @Cephreports @JCephalalgia @Simona_Sacco_ @ihs_official journals.sagepub.com/doi/10.1177/25…

📢 We are delighted to officially welcome the 2025/2026 Cephalalgia Reviewer Academy Fellows! 🎉 These outstanding early-career researchers from around the world have been selected for their commitment to excellence in headache research and scientific publishing. Over the next…

A study from Sweden shows people with higher income and education are much more likely to receive CGRP monoclonal antibodies for migraine — even with subsidies in place. Paper: journals.sagepub.com/doi/full/10.11… Podcast: youtu.be/nTyO42b7OYI?si… #migraine #headache #CGRP #healthequity
📢 Call for Papers: Digital Headache 🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders. Introduction The…

🧠 Psychedelics & Ketamine in Cluster Headache: A Case Series 🌈💊 📄 Cephalalgia Reports | doi.org/10.1177/251581… 🔬 Leighton J, Lau C, Granata L, et al. Can serotonergic psychedelics and ketamine offer relief where standard treatments fail? This exploratory case series of 9…

💥 New Insights on Oxygen Therapy in Cluster Headache 🧠💨 High Flow vs Ultra-High Flow (Demand Valve) Oxygen Delivery: A Patient Experience Survey 📄 Cephalalgia Reports doi.org/10.1177/251581…)) 🔬 Goadsby PJ, Bahra A, Hobbs V et al. A unique patient-initiated, - funded and…

✨🧠 New Topical Collection in Cephalalgia! ✨🧠 "Toward International Classification of Headache Disorders – 4 (ICHD-4)" 📍OPEN TO SUBMISSIONS As we look ahead to the next edition of the ICHD, this collection invites high-level contributions to address current limitations,…

📢 Call for Papers: Digital Headache 🧠 @JCephalalgia is the official journal of the International Headache Society @ihs_official , a leading international scientific society dedicated to advancing the understanding and treatment of headache disorders. Introduction The…

🧠 New Case Report Alert 📄 in Cephalalgia Reports Post-traumatic trigeminal injury leading to novel-onset orofacial migraine 📚 Cephalalgia Reports | doi.org/10.1177/251581… A compelling case of novel-onset orofacial migraine is described following surgical trauma to the…
